Key result
Acute fulminant myocarditis shows ~95% survival to discharge with no subsequent deaths or heart failure.
Why the study?
There is a lack of large-scale studies focusing on acute fulminant myocarditis and limited knowledge of this disease.
Observational (n=40)
No
Acute fulminant myocarditis in this Chinese cohort was associated with severe initial presentation but had an excellent short- and mid-term prognosis, with 95% survival to discharge.
High survival in this small Chinese cohort supports favorable prognosis possible; leaves open generalizability and need for larger validation studies.
OBJECTIVE: There is still a lack of large-scale studies focusing on acute fulminant myocarditis (AFM) and knowledge of this disease is unimpressive. To better understand the clinical features of AFM and improve the diagnosis and treatment of this disease, we analysed the data of consecutive Chinese AFM patients admitted to our department. METHODS: This retrospective observational study analysed the data of 40 patients with a diagnosis of AFM admitted to our hospital between January 2003 and March 2010. RESULTS: The mean age of patients was 28.5 +/- 18.4 years and 70% of patients were females. 90.0% of patients had a short viral prodrome, 77.5% had cardiogenic shock and 35.0% had multiple organ failure, especially hepatic dysfunction. The most common manifestations in ECG were low voltage in the limb leads (87.5%) and sinus tachycardia (75%). Myocardial infarctions like ECG changes were not uncommon. Left ventricular ejection fraction (LVEF) was significantly reduced (25.3 +/- 7.5%), but the left cardiac sizes were normal. More than 90% of the patients were treated with glucocorticoids. 5.0% needed an intra-aortic balloon pump (IABP), and 35.0% were treated with bi-level positive airway pressure (BiPAP). In all, 39 (95.0%) patients were discharged alive and one man died from ventricular fibrillation. LVEF and left cardiac chambers at follow-up did not change as compared with discharge. No death, new onset heart failure or arrhythmias occurred during the follow-up. CONCLUSIONS: This study describes the clinical features of Chinese AFM patients. The short- and mid-term prognosis of AFM is good. AFM patients may benefit from a treatment with glucocorticoids.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2012) conducted an observational in Acute fulminant myocarditis (n=40). Acute fulminant myocarditis was evaluated on Discharged alive. In a cohort of 40 Chinese patients with acute fulminant myocarditis, 95.0% were discharged alive, and no deaths or new-onset heart failure occurred during follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: